» Articles » PMID: 38885217

Mechanical Force-activated CD109 on Periodontal Ligament Stem Cells Governs Osteogenesis and Osteoclast to Promote Alveolar Bone Remodeling

Overview
Date 2024 Jun 17
PMID 38885217
Authors
Affiliations
Soon will be listed here.
Abstract

Mechanical force-mediated bone remodeling is crucial for various physiological and pathological processes involving multiple factors, including stem cells and the immune response. However, it remains unclear how stem cells respond to mechanical stimuli to modulate the immune microenvironment and subsequent bone remodeling. Here, we found that mechanical force induced increased expression of CD109 on periodontal ligament stem cells (PDLSCs) in vitro and in periodontal tissues from the force-induced tooth movement rat model in vivo, accompanied by activated alveolar bone remodeling. Under mechanical force stimulation, CD109 suppressed the osteogenesis capacity of PDLSCs through the JAK/STAT3 signaling pathway, whereas it promoted PDLSC-induced osteoclast formation and M1 macrophage polarization through paracrine. Moreover, inhibition of CD109 in vivo by lentivirus-shRNA injection increased the osteogenic activity and bone density in periodontal tissues. On the contrary, it led to decreased osteoclast numbers and pro-inflammatory factor secretion in periodontal tissues and reduced tooth movement. Mechanistically, mechanical force-enhanced CD109 expression via the repression of miR-340-5p. Our findings uncover a CD109-mediated mechanical force response machinery on PDLSCs, which contributes to regulating the immune microenvironment and alveolar bone remodeling during tooth movement.

Citing Articles

CD109, a master regulator of inflammatory responses.

Batal A, Garousi S, Finnson K, Philip A Front Immunol. 2025; 15:1505008.

PMID: 39990858 PMC: 11842317. DOI: 10.3389/fimmu.2024.1505008.

References
1.
Lee J, Min C, Bang C, Kwon B, Choi H . Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case-control studies using a national sample cohort. Osteoporos Int. 2020; 32(3):529-538. DOI: 10.1007/s00198-020-05724-2. View

2.
Sakakura H, Mii S, Hagiwara S, Kato T, Yamamoto N, Hibi H . CD109 is a component of exosome secreted from cultured cells. Biochem Biophys Res Commun. 2015; 469(4):816-22. DOI: 10.1016/j.bbrc.2015.12.063. View

3.
Litvinov I, Bizet A, Binamer Y, Jones D, Sasseville D, Philip A . CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis. Exp Dermatol. 2011; 20(8):627-32. DOI: 10.1111/j.1600-0625.2011.01288.x. View

4.
Zhou S, Sosina O, Bovijn J, Laurent L, Sharma V, Akbari P . Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis. Nat Genet. 2023; 55(8):1277-1287. DOI: 10.1038/s41588-023-01444-5. View

5.
Thompson W, Rubin C, Rubin J . Mechanical regulation of signaling pathways in bone. Gene. 2012; 503(2):179-93. PMC: 3371109. DOI: 10.1016/j.gene.2012.04.076. View